BDPT (BioAdaptives) Cyclically Adjusted PB Ratio: (As of Jul. 11, 2026)


What is BioAdaptives Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioAdaptives  (OTCPK:BDPT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioAdaptives Cyclically Adjusted PB Ratio Related Terms


BioAdaptives Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for BioAdaptives's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAdaptives Cyclically Adjusted PB Ratio Chart

BioAdaptives Annual Data
Trend Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioAdaptives Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BDPT vs NBND, BSFC, MEHA: Cyclically Adjusted PB Ratio Comparison

For the Packaged Foods subindustry, BioAdaptives's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioAdaptives Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Cyclically Adjusted PB Ratio falls into.



BioAdaptives Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioAdaptives's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, BioAdaptives's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.178/330.2130*330.2130
=-0.178

Current CPI (Mar. 2026) = 330.2130.

BioAdaptives Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.000 234.812 0.000
201503 -0.294 236.119 -0.411
201506 -1.612 238.638 -2.231
201509 -1.976 237.945 -2.742
201512 -2.388 236.525 -3.334
201603 -1.316 238.132 -1.825
201606 -1.558 241.018 -2.135
201609 -1.684 241.428 -2.303
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 -5.597 251.233 -7.357
201903 0.000 254.202 0.000
201906 -5.960 256.143 -7.683
201909 -6.119 256.759 -7.870
201912 -6.774 256.974 -8.705
202003 -7.935 258.115 -10.151
202006 -10.508 257.797 -13.460
202009 -9.565 260.280 -12.135
202012 -9.921 260.474 -12.577
202103 -4.741 264.877 -5.910
202106 -6.145 271.696 -7.468
202109 -5.071 274.310 -6.104
202112 -3.224 278.802 -3.819
202203 -3.594 287.504 -4.128
202206 -2.897 296.311 -3.228
202209 -1.801 296.808 -2.004
202212 -0.862 296.797 -0.959
202303 -0.636 301.836 -0.696
202306 -0.437 305.109 -0.473
202309 -0.222 307.789 -0.238
202312 -0.276 306.746 -0.297
202403 -0.234 312.332 -0.247
202406 -0.234 314.175 -0.246
202409 -0.220 315.301 -0.230
202412 -0.178 315.605 -0.186
202503 -0.174 319.799 -0.180
202506 -0.114 322.561 -0.117
202509 -0.134 324.800 -0.136
202512 -0.177 324.054 -0.180
202603 -0.178 330.213 -0.178

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioAdaptives Business Description

Address 2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.